HIGH POINT, N.C.--(BUSINESS WIRE)--vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease and diabetes, today announced that Company management will present a corporate overview at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on Wednesday, July 13, 2016 at 8:00 a.m. ET in New York City.
